Careers Zobio Drug Discovery Technology 2 company, 1 promise: accelerating discoveries and developing innovative treatments đź’Ş follow our exciting story and stay tuned to witness the positive impac. Watch the interview of fabrice viviano, ceo of oncodesign services, and gregg siegal, ceo of zobio : oncodesign services (ods) is a leading cro specializing in drug discovery and preclinical services.
Capabilities Zobio Drug Discovery Technology Oncodesign services & zobio] "we're active in the very early stage of drug discovery from gene to lead " discover our story through fabrice viviani, phd and gregg siegal's interview!. Zobio will join forces with oncodesign services (ods), a leading contract research organization (cro) specializing in drug discovery and preclinical services with notable expertise in oncology and immuno inflammation. Dr. gregg siegal, ceo of zobio said: “we are truly excited about the opportunity to combine our bestin class fragment based drug discovery platform with the expertise of oncodesign services. Oncodesign services, a french oncology specialist that provides clinical services, has acquired dutch cro zobio for an undisclosed price.
Oncodesign Services X Zobio Itw Discover Our New Story Oncodesign Dr. gregg siegal, ceo of zobio said: “we are truly excited about the opportunity to combine our bestin class fragment based drug discovery platform with the expertise of oncodesign services. Oncodesign services, a french oncology specialist that provides clinical services, has acquired dutch cro zobio for an undisclosed price. Dijon, france & leiden, the netherlands, january 23rd, 2024 – oncodesign services (ods) announces its international expansion through the acquisition of zobio, a dutch cro expert in biophysics based small molecule drug discovery. This acquisition allows oncodesign services to extend upstream its hit to ind capabilities to a fully integrated gene to ind1 offering in the small molecule preclinical value chain. Oncodesign services (ods), a leading contract research organization specialized in drug discovery and preclinical services, announces its international expansion through the acquisition of zobio, a dutch cro expert in biophysics based small molecule drug discovery. 2 company, 1 promise: accelerating discoveries and developing innovative treatments 💪 follow our exciting story and stay tuned to witness the positive impac.
Oncodesign Services On Linkedin Interview Zobio X Oncodesign Services Dijon, france & leiden, the netherlands, january 23rd, 2024 – oncodesign services (ods) announces its international expansion through the acquisition of zobio, a dutch cro expert in biophysics based small molecule drug discovery. This acquisition allows oncodesign services to extend upstream its hit to ind capabilities to a fully integrated gene to ind1 offering in the small molecule preclinical value chain. Oncodesign services (ods), a leading contract research organization specialized in drug discovery and preclinical services, announces its international expansion through the acquisition of zobio, a dutch cro expert in biophysics based small molecule drug discovery. 2 company, 1 promise: accelerating discoveries and developing innovative treatments 💪 follow our exciting story and stay tuned to witness the positive impac.
Comments are closed.